Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armida D'Incecco

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Lung Cancer|March 18, 2009
Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot studyCarmelo Tibaldi, Enrica Mazzoni, Giandomenico Arcabasso, et al.
Journal of Thoracic Disease|May 16, 2022
Multidisciplinary and real life data: practical management of <i>epidermal growth factor receptor</i> (<i>EGFR</i>) mutant non-small cell lung cancer (NSCLC)Armida D'Incecco, Katia Cannita, Francesco Martella, et al.
Clinical Lung Cancer|September 15, 2010
Second-line treatment for non-small-cell lung cancer: one size does not fit allSara Caponi, Enrico Vasile, Laura Ginocchi, et al.
Frontiers in Surgery|August 22, 2022
Chest wall reconstruction in benign and malignant tumors with non-rigid materials: An overviewSara Colella, Alessandro Brandimarte, Roberta Marra, et al.
Translational Lung Cancer Research|September 12, 2022
Efficacy and safety of anlotinib combined with carboplatin and pemetrexed as first-line induction therapy followed by anlotinib plus pemetrexed as maintenance therapy in <i>EGFR/ALK</i> wild-type advanced non-squamous non-small cell lung cancer in China: a multicenter, single-arm trialZhen He, Xiuli Yang, Tianjiang Ma, et al.
International Journal of Oncology|July 4, 2013
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular featuresAlessandra Capodanno, Laura Boldrini, Agnese Proietti, et al.
Plos One|May 9, 2015
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility StudyManolo D'Arcangelo, Matilde Todaro, Jessica Salvini, et al.
Science Signaling|January 19, 2017
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancerRobert M Gemmill, Patrick Nasarre, Joyce Nair-Menon, et al.
The Lancet. Respiratory Medicine|May 19, 2018
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 studyLuana Calabrò, Aldo Morra, Diana Giannarelli, et al.
Clinical Colorectal Cancer|February 8, 2014
MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodiesFederico Cappuzzo, Andrea Sacconi, Lorenza Landi, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Lung Cancer|March 18, 2009
Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot studyCarmelo Tibaldi, Enrica Mazzoni, Giandomenico Arcabasso, et al.
Journal of Thoracic Disease|May 16, 2022
Multidisciplinary and real life data: practical management of <i>epidermal growth factor receptor</i> (<i>EGFR</i>) mutant non-small cell lung cancer (NSCLC)Armida D'Incecco, Katia Cannita, Francesco Martella, et al.
Clinical Lung Cancer|September 15, 2010
Second-line treatment for non-small-cell lung cancer: one size does not fit allSara Caponi, Enrico Vasile, Laura Ginocchi, et al.
Frontiers in Surgery|August 22, 2022
Chest wall reconstruction in benign and malignant tumors with non-rigid materials: An overviewSara Colella, Alessandro Brandimarte, Roberta Marra, et al.
Translational Lung Cancer Research|September 12, 2022
Efficacy and safety of anlotinib combined with carboplatin and pemetrexed as first-line induction therapy followed by anlotinib plus pemetrexed as maintenance therapy in <i>EGFR/ALK</i> wild-type advanced non-squamous non-small cell lung cancer in China: a multicenter, single-arm trialZhen He, Xiuli Yang, Tianjiang Ma, et al.
International Journal of Oncology|July 4, 2013
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular featuresAlessandra Capodanno, Laura Boldrini, Agnese Proietti, et al.
Plos One|May 9, 2015
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility StudyManolo D'Arcangelo, Matilde Todaro, Jessica Salvini, et al.
Science Signaling|January 19, 2017
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancerRobert M Gemmill, Patrick Nasarre, Joyce Nair-Menon, et al.
The Lancet. Respiratory Medicine|May 19, 2018
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 studyLuana Calabrò, Aldo Morra, Diana Giannarelli, et al.
Clinical Colorectal Cancer|February 8, 2014
MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodiesFederico Cappuzzo, Andrea Sacconi, Lorenza Landi, et al.
Pageof 4